JESSICA MARTIN: Open Payments
NPI 1255750808 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $187 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Alkermes, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $13 |
Products named: Kerendia, VIVITROL, FARXIGA, JARDIANCE, Korlym, VRAYLAR, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, IMFINZI.
Industry payments across SC — which companies pay providers there.
